clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Better Heart Health Early on May Offset Risk of Pregnancy-Related Hypertension
News & Features
Five Features Underlie Immunotherapy Response
News & Features
Antibiotic Use Linked to Increased Risk of Inflammatory Bowel Disease
Informatics
33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs
News & Features
New Tool Predicts Severity of TNBC
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Agena Biosciences, Manchester University Partner on Pharmacogenomics Education
Agena Bioscience
Molecular Dx
Agena Biosciences, Manchester University Partner on Pharmacogenomics Education
Chris Anderson
-
November 30, 2021
0
Informatics
Agena, N-of-One Partner on Cancer Genomic Data Interpretation
Inside Precision Medicine Staff Writer
-
October 5, 2017
0
Molecular Dx
Agena to Co-Promote Clinical Dx Technology With HeartGenetics’ Software, Assays
Inside Precision Medicine Staff Writer
-
July 18, 2017
0
Related Content
Five Features Underlie Immunotherapy Response
Non-Coding DNA Found to Be Major Driver of T-Lineage Acute Lymphoblastic Leukemia
Immunogenomics is on the Way Up
Why Equity Needs to Become Obligatory
Inside Precision Medicine
![Agena Bioscience and N-of-One will partner to offer interpretation of cancer genomic data generated by Agena’s MassARRAY® System. [Source: iStock/© agsandrew]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1284.jpeg "Agena, N-of-One Partner on Cancer Genomic Data Interpretation")
![Agena Bioscience will co-promote its MassARRAY® DX clinical diagnostics technology with HeartGenetics' genetic testing software (pictured) and other CE-IVD marked products. [HeartGenetics]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1170.jpeg "Agena to Co-Promote Clinical Dx Technology With HeartGenetics’ Software, Assays")
